These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7990261)

  • 21. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and pharmacokinetic evaluation of cefpodoxime proxetil in children].
    Sakata H; Kakehashi H; Fujita K; Yoshioka H; Iseki K; Murono K; Takahashi Y
    Jpn J Antibiot; 1989 Jul; 42(7):1456-63. PubMed ID: 2810721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 25. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of clinical efficacy and safety of cefpodoxime proxetil (CPDX-PR) in acute uncomplicated cystitis].
    Furusawa T; Hiratake Y; Mishina T; Ooe H; Maegawa M; Furudama H; Hida S; Itoh M; Inoue S; Nakagawa K
    Hinyokika Kiyo; 1994 Sep; 40(9):853-60. PubMed ID: 7801852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of cefpodoxime proxetil, a new oral cephem, in the treatment of respiratory tract infections with the special reference to community-acquired Streptococcus Pneumoniae infections].
    Akiyama O; Ito T; Ogata M; Okano H; Kabe J; Kawakami M; Kida K; Kudo K; Komatsuzaki K; Konno K
    Jpn J Antibiot; 1995 Apr; 48(4):522-8. PubMed ID: 7783315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.
    Chimura T; Hirayama T; Nakahara M
    Jpn J Antibiot; 1993 Jun; 46(6):482-5. PubMed ID: 8360983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
    Brown RJ; Batts DH; Hughes GS; Greenwald CA
    Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical study of SY5555 dry syrup in the pediatric field].
    Haruta T; Kobayashi Y
    Jpn J Antibiot; 1995 Feb; 48(2):205-9. PubMed ID: 7745810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fundamental and clinical studies of SY5555 in pediatrics].
    Yokota T; Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1995 Jan; 48(1):92-102. PubMed ID: 7699847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
    Fujii R
    Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
    Li JT; Hou J; Kao L
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections.
    Stevens DL; Pien F; Drehobl M
    Diagn Microbiol Infect Dis; 1993 Feb; 16(2):123-9. PubMed ID: 8467623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experience with S-1108 on bacterial infection in the pediatric field].
    Takeda E; Ito M; Kuroda Y
    Jpn J Antibiot; 1993 Dec; 46(12):1096-101. PubMed ID: 8107273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fundamental and clinical studies on cefuzonam in the field of pediatrics].
    Kuno K; Hakamada S; Miyachi Y; Nakashima T; Hayakawa F; Miura K; Miyajima Y
    Jpn J Antibiot; 1987 Feb; 40(2):405-18. PubMed ID: 3599389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.
    Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM
    Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.